---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-337953"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2026-08-06T20:05:28+00:00"
generated_at: "2026-08-06T20:08:01.272436+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q2 revenue $31.6M (+1% YoY); signs $40M HCA refresh deal

## Summary
- Net revenue $31.6M, up 1% YoY and 14% sequentially; recurring revenue $22.1M flat.
- Gross margin 42% (+400 bps YoY); net loss $18.0M vs $18.5M prior year.
- Signed three-year, $40M agreement with HCA Healthcare to refresh Tablo fleet.
- Cash position $151M; net cash used $9.5M in quarter.
- Reiterated FY2026 revenue guidance $125M-$130M (5-9% growth).

## SEC filing metadata
- accession: 0001193125-26-337953
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2026-08-06T20:05:28+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000119312526337953/0001193125-26-337953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000119312526337953/om-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-337953
- JSON: https://secwatch.observer/filing/0001193125-26-337953.json
- Plain text: https://secwatch.observer/filing/0001193125-26-337953.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.